Nicotinamide protected first-phase insulin response (FPIR) and prevented clinical disease in first-degree relatives of type-1 diabetics.

Saved in:
Bibliographic Details
Title: Nicotinamide protected first-phase insulin response (FPIR) and prevented clinical disease in first-degree relatives of type-1 diabetics.
Authors: Olmos PR; Department of Nutrition, Diabetes & Metabolism, College of Medicine, Pontificia Universidad Católica de Chile, Alameda 340, Santiago, Chile. polmos@med.puc.cl, Hodgson MI, Maiz A, Manrique M, De Valdés MD, Foncea R, Acosta AM, Emmerich MV, Velasco S, Muñiz OP, Oyarzún CA, Claro JC, Bastías MJ, Toro LA
Source: Diabetes research and clinical practice [Diabetes Res Clin Pract] 2006 Mar; Vol. 71 (3), pp. 320-33. Date of Electronic Publication: 2005 Oct 17.
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8508335 Publication Model: Print-Electronic Cited Medium: Print ISSN: 0168-8227 (Print) Linking ISSN: 01688227 NLM ISO Abbreviation: Diabetes Res Clin Pract Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:0168-8227
DOI:10.1016/j.diabres.2005.07.009